Literature DB >> 2550613

Obesity modifies the adrenergic status of dog adipose tissue.

M Taosis1, P Valet, L Estan, M Lafontan, P Montastruc, M Berlan.   

Abstract

The relative proportion of antilipolytic alpha-2 and lipolytic beta adrenoceptors and the adrenoceptors was studied in adipocytes from lean and obese dogs. The modification of the adrenergic status in the adipose tissue from obese dogs consists of an increase in alpha-2 adrenoceptor number (identified by [3H]yohimbine) and a decrease in beta adrenoceptor number (identified by [3H]dihydroalprenolol). Neither the number of beta adrenoceptors in the leukocytes nor the number of alpha-2 adrenoceptors in the platelets were altered in obesity. This predominance of alpha-2 adrenoceptors in adipocytes from obese dogs induced a reduction of the lipolytic efficacy of epinephrine (i.e., increase in the concentration able to induce half-maximal stimulation of lipolysis). Moreover, the number of beta adrenoceptors in the high-affinity state was increased in adipose tissue from obese dogs. It is concluded first that the striking modifications in the adrenergic status of the adipose tissue in obesity is specific to this tissue and secondly that the rise of the beta adrenoceptor in the high-affinity state could explain the fact that catecholamines remain lipolytic agents and that weight loss is increased by starvation in the obese dog.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550613

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

1.  Functional evidence that alpha 2A-adrenoceptors are responsible for antilipolysis in human abdominal fat cells.

Authors:  G Tarkovács; C Blandizzi; E S Vizi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-01       Impact factor: 3.000

2.  Alpha2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes. A paracrine signal for preadipocyte growth.

Authors:  P Valet; C Pagès; O Jeanneton; D Daviaud; P Barbe; M Record; J S Saulnier-Blache; M Lafontan
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

3.  Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta 2-adrenoceptors.

Authors:  S Reynisdottir; H Wahrenberg; K Carlström; S Rössner; P Arner
Journal:  Diabetologia       Date:  1994-04       Impact factor: 10.122

4.  A pathogenic role of visceral fat beta 3-adrenoceptors in obesity.

Authors:  F Lönnqvist; A Thöme; K Nilsell; J Hoffstedt; P Arner
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

5.  β3-Adrenergic receptor downregulation leads to adipocyte catecholamine resistance in obesity.

Authors:  Joseph M Valentine; Maryam Ahmadian; Omer Keinan; Mohammad Abu-Odeh; Peng Zhao; Xin Zhou; Mark P Keller; Hui Gao; Ruth T Yu; Christopher Liddle; Michael Downes; Jin Zhang; Aldons J Lusis; Alan D Attie; Ronald M Evans; Mikael Rydén; Alan R Saltiel
Journal:  J Clin Invest       Date:  2022-01-18       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.